[TENAGA] QoQ Cumulative Quarter Result on 31-Dec-2018 [#4]

Announcement Date
28-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- -3.48%
YoY- 35.13%
View:
Show?
Cumulative Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 38,762,600 26,120,800 13,244,800 50,392,500 37,845,700 24,771,900 12,274,000 115.10%
PBT 4,702,900 3,156,400 2,073,600 5,046,600 4,843,900 3,939,300 2,415,400 55.86%
Tax -842,000 -505,100 -552,400 -1,301,600 -947,300 -554,100 -298,600 99.46%
NP 3,860,900 2,651,300 1,521,200 3,745,000 3,896,600 3,385,200 2,116,800 49.22%
-
NP to SH 3,875,900 2,673,000 1,556,800 3,723,700 3,858,000 3,357,000 2,119,700 49.47%
-
Tax Rate 17.90% 16.00% 26.64% 25.79% 19.56% 14.07% 12.36% -
Total Cost 34,901,700 23,469,500 11,723,600 46,647,500 33,949,100 21,386,700 10,157,200 127.53%
-
Net Worth 57,382,980 58,498,181 57,696,331 57,716,936 57,861,523 58,929,439 57,803,260 -0.48%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div 1,706,066 1,706,066 - 3,023,068 1,717,176 1,716,358 - -
Div Payout % 44.02% 63.83% - 81.18% 44.51% 51.13% - -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 57,382,980 58,498,181 57,696,331 57,716,936 57,861,523 58,929,439 57,803,260 -0.48%
NOSH 5,686,888 5,686,888 5,686,888 5,686,888 5,678,180 5,678,180 5,665,986 0.24%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 9.96% 10.15% 11.49% 7.43% 10.30% 13.67% 17.25% -
ROE 6.75% 4.57% 2.70% 6.45% 6.67% 5.70% 3.67% -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 681.61 459.32 232.90 887.97 667.14 436.88 216.63 114.57%
EPS 68.16 47.00 27.38 65.62 68.01 59.20 37.41 49.12%
DPS 30.00 30.00 0.00 53.27 30.27 30.27 0.00 -
NAPS 10.0904 10.2865 10.1455 10.1704 10.1997 10.3929 10.2018 -0.72%
Adjusted Per Share Value based on latest NOSH - 5,686,888
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 668.68 450.60 228.48 869.30 652.86 427.33 211.73 115.10%
EPS 66.86 46.11 26.86 64.24 66.55 57.91 36.57 49.46%
DPS 29.43 29.43 0.00 52.15 29.62 29.61 0.00 -
NAPS 9.8989 10.0912 9.9529 9.9565 9.9814 10.1656 9.9714 -0.48%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 13.64 13.84 12.66 13.60 15.46 14.64 16.24 -
P/RPS 2.00 3.01 5.44 1.53 2.32 3.35 7.50 -58.53%
P/EPS 20.01 29.45 46.25 20.73 22.73 24.73 43.41 -40.29%
EY 5.00 3.40 2.16 4.82 4.40 4.04 2.30 67.73%
DY 2.20 2.17 0.00 3.92 1.96 2.07 0.00 -
P/NAPS 1.35 1.35 1.25 1.34 1.52 1.41 1.59 -10.32%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 27/11/19 30/08/19 28/05/19 28/02/19 27/11/18 30/08/18 25/05/18 -
Price 13.56 13.96 11.66 13.42 14.72 15.68 15.04 -
P/RPS 1.99 3.04 5.01 1.51 2.21 3.59 6.94 -56.48%
P/EPS 19.90 29.70 42.59 20.45 21.64 26.48 40.20 -37.39%
EY 5.03 3.37 2.35 4.89 4.62 3.78 2.49 59.73%
DY 2.21 2.15 0.00 3.97 2.06 1.93 0.00 -
P/NAPS 1.34 1.36 1.15 1.32 1.44 1.51 1.47 -5.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment